Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen don't worsen illness or cause death in hospitalized COVID-19 patients, a new study involving more than 72,000 people in the United Kingdom suggests.In the observational study, published late last week in The Lancet Rheumatology, a team led by researchers from the University of Edinburgh enrolled 72,179 COVID-19 patients from 255 UK healthcare centers who had death data available from Jan 17 to Aug 10, 2020.
Of those patients, 4,211 (5.8%) had a record of taking NSAIDs in the 14 days before hospitalization.The authors called it the largest ongoing prospective study of its kind and did not consider aspirin an NSAID for their analysis.Roughly one third of the 4,211